• agbiopro

UK Immune Cell Therapy Biotech Founded with €40M Series A

Updated: Jun 7, 2019

Quell Therapeutics, a London-based biotech developing immune cell therapies to target transplant rejection and autoimmune and inflammatory diseases.


7 views0 comments